GREY MICHAEL G
Insider CIK 1240122 · BMRN Director · HZNP Director · MRTX Director · OKUR Executive Chairman, Director · SPRB Executive Chairman, Director · MIRM Executive Chairman, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-06-15 | 2026-06-17 | 1,980 | — | $0 | 1,980 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-06-15 | 2026-06-17 | 3,772 | — | $0 | 3,772 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 7,650 | — | $0 | 7,650 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2026-05-21 | 2026-05-26 | 1,700 | — | $0 | 1,700 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-12-19 | 2025-12-23 | 50,000 | — | $0 | 181,176 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-12-19 | 2025-12-23 | 50,000 | $2.94 | $147.0K | 50,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-12-19 | 2025-12-23 | 50,000 | $78.00 | $3.90M | 0 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2025-12-11 | 2025-12-15 | 666 | — | $0 | 666 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | D To issuer deriv | 2025-12-11 | 2025-12-15 | 133 | — | $0 | 0 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2025-12-11 | 2025-12-15 | 133 | — | $0 | 133 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | D To issuer deriv | 2025-12-11 | 2025-12-15 | 1,499 | — | $0 | 0 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2025-12-11 | 2025-12-15 | 1,499 | — | $0 | 1,499 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | D To issuer deriv | 2025-12-11 | 2025-12-15 | 1,255 | — | $0 | 0 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2025-12-11 | 2025-12-15 | 1,255 | — | $0 | 1,255 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | D To issuer deriv | 2025-12-11 | 2025-12-15 | 387 | — | $0 | 0 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2025-12-11 | 2025-12-15 | 387 | — | $0 | 387 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | D To issuer deriv | 2025-12-11 | 2025-12-15 | 400 | — | $0 | 0 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2025-12-11 | 2025-12-15 | 400 | — | $0 | 400 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | D To issuer deriv | 2025-12-11 | 2025-12-15 | 666 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-12-01 | 2025-12-02 | 50,000 | — | $0 | 231,176 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-12-01 | 2025-12-02 | 50,000 | $2.94 | $147.0K | 50,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-12-01 | 2025-12-02 | 50,000 | $74.00 | $3.70M | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-11-21 | 2025-11-25 | 50,000 | — | $0 | 281,176 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-11-21 | 2025-11-25 | 50,000 | $2.94 | $147.0K | 50,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-11-21 | 2025-11-25 | 50,000 | $70.00 | $3.50M | 0 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2025-07-22 | 2025-07-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-05-29 | 2025-06-02 | 6,268 | — | $0 | 6,268 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-05-29 | 2025-06-02 | 3,977 | — | $0 | 3,977 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 7,650 | — | $0 | 7,650 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2024-10-04 | 2024-10-08 | 15,300 | — | $0 | 15,300 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | G Gift | 2024-09-27 | 2024-10-01 | 102,788 | — | $0 | 186,410 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 8,779 | — | $0 | 8,779 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 5,703 | — | $0 | 5,703 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2024-05-22 | 2024-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 4,016 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 8,548 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 23,092 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 31,153 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 32,161 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer | 2023-10-06 | 2023-10-06 | 48,031 | $116.50 | $5.60M | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer | 2023-10-06 | 2023-10-06 | 10,000 | $116.50 | $1.17M | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer | 2023-10-06 | 2023-10-06 | 39,361 | $116.50 | $4.59M | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-09-28 | 2023-09-28 | 20,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2023-09-28 | 2023-09-28 | 20,000 | $15.96 | $319.2K | 39,361 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2023-09-14 | 2023-09-14 | 14,216 | — | $0 | 331,176 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2023-09-14 | 2023-09-14 | 14,216 | $32.00 | $454.9K | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2023-09-14 | 2023-09-14 | 14,216 | $2.94 | $41.8K | 14,216 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2023-09-13 | 2023-09-14 | 392 | — | $0 | 345,392 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2023-09-13 | 2023-09-14 | 392 | $2.94 | $1.2K | 392 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2023-09-13 | 2023-09-14 | 392 | $32.00 | $12.5K | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2023-07-27 | 2023-07-28 | 4,016 | — | $0 | 4,016 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | G Gift | 2023-07-26 | 2023-07-27 | 50,000 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2023-06-12 | 2023-06-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2023-06-08 | 2023-06-09 | 14,608 | — | $0 | 345,784 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2023-06-08 | 2023-06-09 | 14,608 | $2.94 | $42.9K | 14,608 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2023-06-08 | 2023-06-09 | 14,608 | $29.00 | $423.6K | 0 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | A Award deriv | 2023-06-06 | 2023-06-08 | 17,500 | — | $0 | 17,500 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2023-05-25 | 2023-05-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2023-05-03 | 2023-05-04 | 14,608 | — | $0 | 360,392 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2023-05-03 | 2023-05-04 | 14,608 | $2.94 | $42.9K | 14,608 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2023-05-03 | 2023-05-04 | 14,608 | $28.00 | $409.0K | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-04-28 | 2023-05-02 | 3,913 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2023-04-28 | 2023-05-02 | 3,913 | — | $0 | 19,361 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | M Exercise deriv | 2022-08-31 | 2022-09-02 | 50,000 | — | $0 | 67,406 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | M Exercise | 2022-08-31 | 2022-09-02 | 50,000 | $1.97 | $98.5K | 50,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2022-06-02 | 2022-06-06 | 17,000 | — | $0 | 17,000 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | A Award deriv | 2022-06-01 | 2022-06-03 | 17,500 | — | $0 | 17,500 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2022-05-25 | 2022-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-04-29 | 2022-05-02 | 4,223 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2022-04-29 | 2022-05-02 | 4,223 | — | $0 | 66,513 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2022-04-29 | 2022-05-02 | 1,139 | $98.56 | $112.3K | 65,374 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2022-04-28 | 2022-05-02 | 3,913 | — | $0 | 3,913 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2021-12-16 | 2021-12-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-07-22 | 2021-07-23 | 5,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-07-22 | 2021-07-23 | 1,000 | $100.00 | $100.0K | 4,000 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-07-22 | 2021-07-23 | 5,000 | $2.37 | $11.8K | 5,000 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-07-22 | 2021-07-23 | 4,000 | $100.05 | $400.2K | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2021-06-04 | 2021-06-08 | 17,000 | — | $0 | 17,000 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2021-05-20 | 2021-05-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-04-30 | 2021-04-30 | 11,098 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2021-04-30 | 2021-04-30 | 2,993 | $94.62 | $283.2K | 70,395 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-04-30 | 2021-04-30 | 11,098 | — | $0 | 73,388 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2021-04-29 | 2021-04-30 | 4,223 | — | $0 | 4,223 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | C Conversion deriv | 2021-04-13 | 2021-04-15 | 90,222 | — | $0 | 0 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | C Conversion | 2021-04-13 | 2021-04-15 | 20,162 | — | $0 | 444,762 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-04-12 | 2021-04-13 | 15,000 | — | $0 | 5,000 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-04-12 | 2021-04-13 | 15,000 | $90.28 | $1.35M | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-04-12 | 2021-04-13 | 15,000 | $2.37 | $35.5K | 15,000 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | A Award deriv | 2021-04-08 | 2021-04-12 | 14,000 | — | $0 | 14,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-03-05 | 2021-03-09 | 5,000 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-03-05 | 2021-03-09 | 5,000 | $26.49 | $132.4K | 47,840 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-03-05 | 2021-03-09 | 5,000 | $76.28 | $381.4K | 42,840 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 2,155 | — | $0 | 2,155 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2021-01-15 | 2021-01-20 | 1,475 | — | $0 | 5,731 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-12-14 | 2020-12-16 | 10,900 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 1,653 | $244.45 | $404.1K | 10,452 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 1,019 | $248.55 | $253.3K | 4,345 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 1,997 | $247.62 | $494.5K | 5,364 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 1,807 | $246.73 | $445.8K | 7,361 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 1,284 | $245.11 | $314.7K | 9,168 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 89 | $249.42 | $22.2K | 4,256 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 1,815 | $243.35 | $441.7K | 12,105 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 857 | $242.29 | $207.6K | 13,920 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 379 | $241.22 | $91.4K | 14,777 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-12-14 | 2020-12-16 | 10,900 | $16.84 | $183.6K | 15,156 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2020-08-05 | 2020-08-07 | 1,755 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2020-08-05 | 2020-08-07 | 1,755 | $73.35 | $128.7K | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2020-08-05 | 2020-08-07 | 1,755 | $3.95 | $6.9K | 1,755 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-08-03 | 2020-08-05 | 2,500 | — | $0 | 5,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-08-03 | 2020-08-05 | 2,500 | $120.35 | $300.9K | 42,840 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-08-03 | 2020-08-05 | 2,500 | $26.49 | $66.2K | 45,340 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2020-07-22 | 2020-07-22 | 1,755 | — | $0 | 1,755 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2020-07-22 | 2020-07-22 | 1,755 | $60.00 | $105.3K | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2020-07-22 | 2020-07-22 | 1,755 | $3.95 | $6.9K | 1,755 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2020-06-25 | 2020-06-26 | 1,755 | — | $0 | 3,510 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2020-06-25 | 2020-06-26 | 1,755 | $55.00 | $96.5K | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2020-06-25 | 2020-06-26 | 1,755 | $3.95 | $6.9K | 1,755 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2020-06-11 | 2020-06-15 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-05-27 | 2020-05-29 | 4,300 | — | $0 | 42,840 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2020-05-22 | 2020-05-26 | 10,530 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2020-05-22 | 2020-05-26 | 10,530 | $7.84 | $82.6K | 10,530 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2020-05-22 | 2020-05-26 | 10,530 | $48.77 | $513.5K | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2020-05-02 | 2020-05-04 | 15,390 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2020-05-02 | 2020-05-04 | 15,390 | — | $0 | 62,290 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2020-04-30 | 2020-05-04 | 11,098 | — | $0 | 11,098 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2020-01-03 | 2020-01-07 | 4,000 | — | $0 | 4,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2020-01-03 | 2020-01-07 | 2,000 | — | $0 | 4,256 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2020-01-01 | 2020-01-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-11-12 | 2019-11-14 | 3,500 | — | $0 | 10,900 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-11-12 | 2019-11-14 | 3,500 | $16.84 | $58.9K | 5,298 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-11-12 | 2019-11-14 | 3,042 | $102.44 | $311.6K | 2,256 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-08-12 | 2019-08-14 | 3,500 | — | $0 | 14,400 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-08-12 | 2019-08-14 | 1,100 | $92.34 | $101.6K | 2,708 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-08-12 | 2019-08-14 | 650 | $93.18 | $60.6K | 2,058 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-08-12 | 2019-08-14 | 260 | $93.98 | $24.4K | 1,798 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-08-12 | 2019-08-14 | 1,032 | $91.20 | $94.1K | 3,808 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-08-12 | 2019-08-14 | 3,500 | $16.84 | $58.9K | 4,840 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion deriv | 2019-07-22 | 2019-07-24 | 63,585 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion | 2019-07-22 | 2019-07-24 | 7,948 | — | $0 | 289,198 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-06-04 | 2019-06-06 | 4,430 | — | $0 | 38,540 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-05-13 | 2019-05-15 | 7,100 | — | $0 | 17,900 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-05-13 | 2019-05-15 | 300 | $66.08 | $19.8K | 1,340 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-05-13 | 2019-05-15 | 7,100 | $16.84 | $119.6K | 7,100 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-05-13 | 2019-05-15 | 5,460 | $65.26 | $356.3K | 1,640 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2019-05-03 | 2019-05-06 | 15,320 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2019-05-03 | 2019-05-06 | 4,132 | $26.54 | $109.7K | 46,900 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2019-05-03 | 2019-05-06 | 15,320 | — | $0 | 51,032 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2019-05-02 | 2019-05-06 | 15,390 | — | $0 | 15,390 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2019-01-17 | 2019-01-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-06-05 | 2018-06-07 | 4,300 | — | $0 | 34,110 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2018-05-03 | 2018-05-07 | 32,161 | — | $0 | 32,161 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2018-05-03 | 2018-05-07 | 14,054 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2018-05-03 | 2018-05-07 | 15,320 | — | $0 | 15,320 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2018-05-03 | 2018-05-07 | 3,790 | $13.87 | $52.6K | 35,712 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2018-05-03 | 2018-05-07 | 14,054 | — | $0 | 39,502 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2018-01-18 | 2018-01-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2017-06-06 | 2017-06-08 | 4,910 | — | $0 | 4,910 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-06-06 | 2017-06-08 | 2,050 | — | $0 | 29,810 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2017-05-17 | 2017-05-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HZNP Horizon Pharma plc | P Buy | 2017-05-10 | 2017-05-10 | 10,000 | $9.48 | $94.8K | 25,448 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2017-05-03 | 2017-05-04 | 13,953 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2017-05-03 | 2017-05-04 | 31,153 | — | $0 | 31,153 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2017-05-03 | 2017-05-04 | 14,054 | — | $0 | 14,054 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2017-05-03 | 2017-05-04 | 3,763 | $15.12 | $56.9K | 15,448 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2017-05-03 | 2017-05-04 | 13,953 | — | $0 | 19,211 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2016-06-06 | 2016-06-08 | 4,440 | — | $0 | 4,440 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-06-06 | 2016-06-08 | 1,510 | — | $0 | 27,760 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2016-05-18 | 2016-05-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2016-05-06 | 2016-05-10 | 5,258 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2016-05-06 | 2016-05-10 | 5,258 | — | $0 | 5,258 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2016-05-03 | 2016-05-05 | 23,092 | — | $0 | 23,092 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2016-05-03 | 2016-05-05 | 13,953 | — | $0 | 13,953 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2016-02-22 | 2016-02-23 | 7,500 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-02-22 | 2016-02-23 | 7,500 | $80.00 | $600.0K | 26,250 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2016-02-22 | 2016-02-23 | 7,500 | $38.59 | $289.4K | 33,750 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-11-16 | 2015-11-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-11-16 | 2015-11-18 | 7,500 | $104.27 | $782.0K | 26,250 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-11-16 | 2015-11-18 | 7,500 | $38.59 | $289.4K | 33,750 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2015-06-10 | 2015-06-18 | 3,300 | — | $0 | 3,300 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2015-06-10 | 2015-06-18 | 1,100 | — | $0 | 26,250 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2015-05-21 | 2015-05-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2015-05-06 | 2015-05-08 | 8,548 | — | $0 | 8,548 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2015-05-06 | 2015-05-08 | 5,258 | — | $0 | 5,258 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2014-11-05 | 2014-11-06 | 25,000 | — | $0 | 25,000 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 10,530 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 20,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 20,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 5,265 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 10,530 | — | $0 | 10,530 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 5,265 | — | $0 | 5,265 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2014-06-27 | 2014-06-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-06-06 | 2014-06-06 | 2,100 | — | $0 | 25,150 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2014-06-04 | 2014-06-06 | 6,600 | — | $0 | 6,600 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-12-11 | 2013-12-13 | 7,500 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-12-11 | 2013-12-13 | 15,000 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-12-11 | 2013-12-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-12-11 | 2013-12-13 | 15,000 | $21.51 | $322.6K | 45,550 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-12-11 | 2013-12-13 | 7,500 | $26.49 | $198.7K | 53,050 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-12-11 | 2013-12-13 | 30,000 | $69.66 | $2.09M | 23,050 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-12-11 | 2013-12-13 | 7,500 | $17.33 | $130.0K | 30,550 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2013-05-31 | 2013-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2013-05-15 | 2013-05-17 | 8,500 | — | $0 | 8,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-05-15 | 2013-05-17 | 3,400 | — | $0 | 23,050 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-03-06 | 2013-03-08 | 15,000 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-03-06 | 2013-03-08 | 15,000 | $60.61 | $909.1K | 19,650 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-03-03 | 2013-03-08 | 15,000 | $14.39 | $215.8K | 34,650 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2012-06-08 | 2013-02-22 | 5,265 | — | $0 | 5,265 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2012-05-08 | 2012-05-10 | 8,500 | — | $0 | 76,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-05-08 | 2012-05-10 | 3,400 | — | $0 | 19,650 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-02-23 | 2012-02-24 | 30,000 | — | $0 | 67,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | D To issuer | 2012-02-23 | 2012-02-24 | 30,000 | $35.36 | $1.06M | 16,250 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-02-23 | 2012-02-24 | 30,000 | $16.92 | $507.6K | 46,250 | SEC↗ |